Salta al contenuto principale

Polyneuropathies

Professionisti Medici

Gli articoli di riferimento professionale sono progettati per essere utilizzati dai professionisti della salute. Sono scritti da medici del Regno Unito e basati su prove di ricerca, linee guida del Regno Unito e europee. Potresti trovare uno dei nostri articoli sulla salute più utile.

Vedi anche gli articoli separati su Storia neurologica ed esame, < a>Esame neurologico degli arti inferiori</a> e Esame neurologico degli arti superiori.

Continua a leggere sotto

What are polyneuropathies?

Polyneuropathies are the most common type of disorder of the peripheral nervous system in adults, especially the elderly, with an estimated prevalence of 5-8%, depending on age.1

Most polyneuropathies are chronic and usually develop over several months. Three main patterns of polyneuropathy can be distinguished and each has a different differential diagnosis:

  • Acute symmetrical peripheral neuropathy.

  • Chronic symmetrical peripheral neuropathy.

  • Multiple mononeuropathy.

Both peripheral and cranial nerves are affected, either by axonal degeneration (nerve becomes electrically inert within one week) or demyelination, which initially leaves the axon intact and results in blockage or slowing of conduction.

Patients with polyneuropathy may present with altered sensation, pain, weakness or autonomic symptoms. Acute symmetrical polyneuropathy (eg, Sindrome di Guillain-Barré) is uncommon.

Sensory polyneuropathy2

  • In sensory polyneuropathy, usually, the feet are affected first.

  • Paraesthesiae, numbness, burning pain, and loss of vibration sense and position sense are prominent. Muscle wasting may occur.

  • The sensory neuropathy may be subacute with ataxia caused by loss of sense of posture.

Autonomic neuropathy3

  • Polyneuropathy often affects the autonomic nervous system.

  • Typical symptoms are constipation, loss of bowel or bladder control and orthostatic hypotension. The skin may become pale and dry and sweating may be reduced.

Hereditary polyneuropathy4

Hereditary causes of polyneuropathy may also cause hammer toes, high arches and scoliosis.

Continua a leggere sotto

The cause of chronic polyneuropathy is often unknown. The most common causes of peripheral neuropathy are:

Others causes include:

Initial tests include:

  • Urine: glucose, protein.

  • Haematology: FBC, erythrocyte sedimentation rate (ESR), vitamin B12, folate.

  • Biochemistry: fasting glucose, renal function, liver function and thyroid function.

Further investigations will depend on the outcome of clinical assessment and initial investigation results:

  • Neurophysiology testing with assessment of distal and proximal nerve stimulation; electrophysiological procedures are helpful in determining the pathological process which may be either an axonopathy, a myelinopathy or a neuronopathy.8

  • Biochemistry: serum protein electrophoresis, serum angiotensin-converting enzyme.

  • Immunology: antinuclear factor, anti-extractable nuclear antigen antibodies (anti-Ro, anti-La), antineutrophil cytoplasmic antigen antibodies.

  • Urine: Bence-Jones protein.

  • Cerebrospinal fluid: cells, protein, immunoglobulin oligoclonal bands.

  • Immunology: anti-HIV antibodies, antineuronal antibodies (Hu, Yo), antigliadin antibodies, serum angiotensin-converting enzyme, antiganglioside antibodies, antimyelin-associated glycoprotein antibodies.

  • Search for carcinoma, lymphoma or solitary myeloma.

  • Molecular genetic tests - eg, for Charcot-Marie-Tooth syndrome.

  • Nerve biopsy may be required.

Continua a leggere sotto

The initial assessment of the diagnosis and underlying cause is usually performed in secondary care. Re-referral may be indicated at a later stage if there is a significant deterioration in symptoms or an alteration in the presentation suggesting a further assessment is required.

Acute multiple mononeuropathy requires urgent assessment, as the most common cause is vasculitis. Prompt treatment with steroids, with or without ciclofosfamide, may prevent further irreversible nerve damage.

  • Preventative and palliative treatments include foot care, weight reduction, sensible footwear and foot orthoses.

  • Patients with severe leg weakness may need walking aids.

  • Simple wrist splints can help weak wrist extension.

  • Disabled patients require help from a multidisciplinary team including an occupational therapist and a physiotherapist.

Farmacologico

  • Specific treatment depends on the cause.

  • Good control of glucose and blood pressure in patients with diabete may improve or at least slow the progress of neuropathy.

  • Chronic inflammatory demyelinative polyneuropathy is treatable with corticosteroids, intravenous immunoglobulin, plasma exchange and some immunosuppressant drugs.9

  • Multifocal motor neuropathy responds to intravenous immunoglobulin, and possibly immunosuppressant drugs.10

  • No specific treatment is available for chronic idiopathic axonal polyneuropathy.

  • Painful neuropathy is difficult to treat. The most useful drugs are amitriptyline, duloxetine, gabapentin or pregabalin.11

  • With loss of sensation, recurrent injury to joints may lead to permanent joint destruction (Charcot joint).12

  • May lead to disability, social isolation or loss of independence, especially in the elderly.

Ulteriori letture e riferimenti

  1. Sommer C, Geber C, Young P, et al; Polyneuropathies. Dtsch Arztebl Int. 2018 Feb 9;115(6):83-90. doi: 10.3238/arztebl.2018.083.
  2. Freeman R, Gewandter JS, Faber CG, et al; Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria. Neurology. 2020 Dec 1;95(22):1005-1014. doi: 10.1212/WNL.0000000000010988. Epub 2020 Oct 14.
  3. Vinik AI, Erbas T; Diabetic autonomic neuropathy. Handb Clin Neurol. 2013;117:279-94. doi: 10.1016/B978-0-444-53491-0.00022-5.
  4. Kramarz C, Rossor AM; Neurological update: hereditary neuropathies. J Neurol. 2022 Sep;269(9):5187-5191. doi: 10.1007/s00415-022-11164-1. Epub 2022 May 21.
  5. Brizzi KT, Lyons JL; Peripheral nervous system manifestations of infectious diseases. Neurohospitalist. 2014 Oct;4(4):230-40. doi: 10.1177/1941874414535215.
  6. Cojocaru IM, Cojocaru M, Silosi I, et al; Peripheral nervous system manifestations in systemic autoimmune diseases. Maedica (Buchar). 2014 Sep;9(3):289-94.
  7. Mirian A, Aljohani Z, Grushka D, et al; Diagnosis and management of patients with polyneuropathy. CMAJ. 2023 Feb 13;195(6):E227-E233. doi: 10.1503/cmaj.220936.
  8. Gwathmey KG, Pearson KT; Diagnosis and management of sensory polyneuropathy. BMJ. 2019 May 8;365:l1108. doi: 10.1136/bmj.l1108.
  9. Said G, Krarup C; Chronic inflammatory demyelinative polyneuropathy. Handb Clin Neurol. 2013;115:403-13. doi: 10.1016/B978-0-444-52902-2.00022-9.
  10. Muley SA, Parry GJ; Multifocal motor neuropathy. J Clin Neurosci. 2012 Sep;19(9):1201-9. doi: 10.1016/j.jocn.2012.02.011. Epub 2012 Jun 27.
  11. Dolore neuropatico – gestione farmacologica: La gestione farmacologica del dolore neuropatico negli adulti in contesti non specialistici; Linee guida cliniche NICE (novembre 2013, ultimo aggiornamento settembre 2020)
  12. Galanis N, Kyriakou A, Delniotis I, et al; Charcot arthropathy: The diagnostic dilemma of a painless, destructive joint. Clin Case Rep. 2019 Dec 11;8(1):224-225. doi: 10.1002/ccr3.2603. eCollection 2020 Jan.

Continua a leggere sotto

Storia dell'articolo

Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.

flu eligibility checker

Chiedi, condividi, connettiti.

Esplora le discussioni, fai domande e condividi esperienze su centinaia di argomenti di salute.

symptom checker

Non ti senti bene?

Valuta i tuoi sintomi online gratuitamente